awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38052141-F238E63E-CD9A-4B2B-824F-AB0A11150F3A
Q38052141-F238E63E-CD9A-4B2B-824F-AB0A11150F3A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38052141-F238E63E-CD9A-4B2B-824F-AB0A11150F3A
A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States.
P2860
Q38052141-F238E63E-CD9A-4B2B-824F-AB0A11150F3A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38052141-F238E63E-CD9A-4B2B-824F-AB0A11150F3A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a814342623169bfcdfe9990002fbd32e20eea04
P2860
A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion.